- Global Pharma News & Resources

Press Releases - 2020-02-10

Date Title Company
10-Feb-2020 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2020 Ended December 31, 2019 and Provides Conference Call Information Elite Pharmaceuticals, Inc.
10-Feb-2020 Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV(TM) (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer Astellas
10-Feb-2020 Janssen Announces Submission to U.S. FDA for New DARZALEX® (Daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple Myeloma Janssen Oncology
10-Feb-2020 Protalix BioTherapeutics Presents Key Clinical Data of Pegunigalsidase Alfa for the Treatment of Fabry Disease at the 16th Annual WORLDSymposium(TM) 2020 Protalix BioTherapeutics, Inc.
10-Feb-2020 Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results Luminex Corporation
10-Feb-2020 Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares Theravance Biopharma, Inc.
10-Feb-2020 Halozyme To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call Halozyme Therapeutics, Inc.
10-Feb-2020 Scottish Medicines Consortium (SMC) says ‘yes’ to targeted combination therapy for both treatment-naïve and previously treated adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation OPEN Health
10-Feb-2020 Sirtex Medical Announces Closing of Strategic Transaction with OncoSec Medical, Inc. Sirtex
10-Feb-2020 Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020 Clarivate Analytics
10-Feb-2020 Vectura announces the appointment of Sharon Johnson, Executive Vice President for Delivery Management New organisational structure to drive innovation, customer focus and growth Vectura Group plc
10-Feb-2020 Nanoform establishes US subsidiary Nanoform
10-Feb-2020 Development of Novodiag® assay for safe and easy molecular testing of novel coronavirus and influenza viruses Automobi Molecular Diagnostic Co., Ltd
10-Feb-2020 HumanOptics AG: Correction of the expected earnings forecast for the current financial year 2019/2020 HumanOptics AG
10-Feb-2020 CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors CollPlant
10-Feb-2020 Compugen to Release Fourth Quarter and Full Year 2019 Results on Thursday, February 20, 2020 Compugen Ltd.
10-Feb-2020 CPhI Southeast Asia Report: executives call for track-and-trace schemes in Southeast Asia CPhI
10-Feb-2020 HPAPI 2020 conference to discuss containment solutions and ADC developments SMi Group Ltd
10-Feb-2020 CO.DON AG adds contract manufacturing to its product portfolio CO.DON AG
10-Feb-2020 4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares (news with additional features) 4basebio AG